Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind study of quadrivalent influenza vaccine versus trivalent Fluarix in children
2010-021073-36Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of influenza virus quadrivalent inactivated vaccine and Fluarix in seasonal influenza (2 arms), sponsored by GSK. Primary endpoints: Humoral immune response to each influenza vaccine strain, Non-inferiority for shared viral strains and 1 more. Started Jul 2010; status: completed.
02
Drugs
influenza virus quadrivalent inactivated vaccineFluarix
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on 2010-021073-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021073-36.